Synthetic analogues of 3-iodothyronamine (T1AM) and uses thereof

The invention aims to the development of new synthetic analogs of 3-iodothyronamine (T1AM), an exponent of a class of endogenous molecules derived from thyroid hormones. The possible main therapeutic uses are:  treatment of obesity and dyslipidemia; neuro-psychiatric and behavioral disorders; neurodegenerative diseases.

Settore:

Life sciences

Research Institution:

Università di Pisa

Publication number:

WO2015151068A1

Technologies, Systems, Applications:

New drugs development,
Biomedical

Technological Priority:

Biotechnologies for health,
Biomedical, pharmaceutical, pharmacological technologies
Pubblicato il: